CoolSculpting, "Paradoxical" Fat Growth, and the Linda Evangelista Story
When supermodel Linda Evangelista revealed that a fat-freezing treatment had left her "brutally disfigured," it put a rare side effect of CoolSculpting on the front pages. For the clinician, this rare complication highlights how important proper consent in aesthetic medicine is.
In 2021, one of the most famous faces of the 1990s did something very brave. Linda Evangelista posted that a cosmetic procedure had left her "permanently deformed" and "unrecognisable," that she'd developed a rare complication called paradoxical adipose hyperplasia, and that the shame and grief of it had sent her into depression and years of hiding away.
It's a genuinely sad story and it is a privilege that Linda chose to share it. I want to delve into it from the point of view of an aesthetic clinician who trains others in this speciality which (like all areas of medicine) is not risk free. I think it’s important to examine this story with compassion for Linda, and without either the tabloid ghoulishness or the reflexive industry defensiveness that tends to follow.
Because the takeaway is more nuanced than "fat-freezing is dangerous." The treatment is, for most people, very safe. What happened to Linda is rare. But her story still matters enormously — just not for the reason the headlines suggested.
First, what CoolSculpting actually is
CoolSculpting is a brand name for cryolipolysis — literally "fat-freezing." The idea is elegant and simple: fat cells are more vulnerable to cold than the skin, nerves and other tissue around them. An applicator suctions up a roll of fat and chills it to a precise temperature that damages the fat cells while sparing everything else. Over the following weeks, your body clears those dead cells away, and the treated pocket gets a bit smaller — usually around a 20–25% reduction in that specific bulge.
Two things to be clear about. It's body contouring, not weight loss — it's for pinchable pockets of stubborn fat in someone already close to their shape, not a treatment for obesity. And for most people, it's well tolerated: the common side effects are temporary and mild — redness, swelling, bruising, tenderness, and often a stretch of numbness in the area that can linger for a few weeks before settling. Nothing there is alarming. It's been FDA-cleared since 2010 and done millions of times. (If you want the full clinical deep-dive — the mechanism, the treatment parameters, and the evidence base — I've written a CPD analysis of cryolipolysis for the Aesthetics Journal that goes under the bonnet properly.)
So far, so reassuring. Now the exception.
Paradoxical adipose hyperplasia
Here's the strange one. In a small number of people, the treated fat does the opposite of what it's supposed to: instead of shrinking, it grows — forming a firm, often well-defined mass, classically in the shape of the applicator that was used. That's paradoxical adipose hyperplasia, or PAH.
A few things to know about it. It typically shows up months after treatment, not straight away — often two to six months later, sometimes longer — which is part of why people (and their practitioners) initially mistake it for ordinary fat regain. It is not dangerous to your health. But it doesn't resolve on its own — there are essentially no reported cases of it simply going away — and correcting it usually means surgery, most often liposuction, once the tissue has softened enough to operate on. So while it won't hurt you medically, it can be genuinely disfiguring and, for obvious reasons, distressing.
This is what Linda Evangelista developed.
How rare is it, honestly?
This is where I want to be frank in both directions, because the truth is reassuring and it deserves an asterisk.
PAH is rare. When CoolSculpting's makers first reported it, the quoted rate was around 1 in 4,000 treatment cycles (0.025%). Independent research has since suggested that was an underestimate: a large multicentre study of over 8,600 cycles found PAH in about 0.15% of cycles — roughly 0.4% of patients, i.e. around 1 in 250 people in that series. Researchers are fairly candid that it's probably been under-reported and misdiagnosed, precisely because it looks, at first, like the fat simply came back.
But — and this genuinely matters — the picture has improved. The same research found that the newer-generation applicators cut PAH rates by more than 75% compared with the older machines that most reported cases involved. And we now know the risk factors: it's notably more common in men, on the abdomen and flanks, and with those older devices. So the honest summary is this: PAH is uncommon, was historically under-recognised, is more likely in certain people and with certain (older) equipment, and is rarer still on modern machines. It is a real risk. It is also a small one.
That "small but real" is the whole point of this article.
Linda's story, told with care
It would be easy — and cruel — to treat Linda Evangelista's case as a curiosity. I'd rather treat it as what it was: a person who was badly let down, and who was courageous about it.
Think about the specific weight of it for her. Her face was her career; she was one of the most photographed women alive. To have a cosmetic procedure — one sold as low-risk, no-downtime — leave her with growths she felt she had to hide, is a particular kind of devastation. In her own words, it didn't just affect her livelihood; it sent her into "deep depression, profound sadness, and the lowest depths of self-loathing." She stopped going out. She hid. For years, a woman famous for being seen couldn't bear to be.
She sued the treatment's maker, alleging she hadn't been properly warned of the risk, and the case settled in 2022. Then she did the harder thing: she spoke about it openly, including on the cover of British Vogue, and allowed the effects to be shown rather than airbrushed away. That took real nerve — and it did the rest of us a service, because it dragged a rare, quietly-ignored complication into daylight, and made "get PAH explained to you" a normal part of the CoolSculpting conversation in a way it simply wasn't before.
She is not a cautionary punchline. She's someone the system failed on informed consent, who turned her own distress into a warning that has protected other people.
Why the story actually matters
Here's the bit I most want you to take away, because it's not the most obvious point at first glance.
The takeaway is not "CoolSculpting is dangerous." For the vast majority of people it's a safe, modestly effective, low-drama treatment, and PAH is a genuinely tiny risk that's smaller still on modern machines. If you scare people off a reasonable procedure over a rare complication, you've overcorrected.
The takeaway is informed consent — and here I want to put on my clinician-and-trainer hat, because this isn't just a nicety, it's the law. Since a landmark 2015 UK Supreme Court case, Montgomery v Lanarkshire Health Board, the legal standard for consent in this country is unambiguously patient-centred. It's no longer enough for a doctor to disclose what they, or a body of their peers, would consider worth mentioning. We are legally required to disclose any "material risk" — and a risk is material if a reasonable person in the patient's position would be likely to attach significance to it, or if we know (or should know) that this particular patient would. Crucially, materiality is not decided by the percentage alone. It's a product of how likely the harm is and how serious it would be if it happened.
Sit PAH against that test and the answer is glaring. A complication that is uncommon but potentially disfiguring, that doesn't go away on its own, and that needs surgery to correct? That is a textbook material risk. The rarity is not a licence to skip it; if anything, the severity makes disclosing it more obligatory, not less. Montgomery essentially wrote Linda's moral instinct — "I had a right to know" — into law.
The failure in stories like hers isn't usually the biology; it's the marketing that sells aesthetic treatments as risk-free and consequence-free, and a consent process that waves the rare stuff away because "it almost never happens." Almost never is not never. The people it happens to are entire human beings, and — legally and morally — they deserved to have been told, in plain language, out loud, before they signed anything.
This is the bit I hammer when I teach: consent is not a form you get signed. It's a conversation you have.
If you're considering it
None of this should frighten you off if it's genuinely right for you. CoolSculpting can be a reasonable option for small, stubborn pockets of fat in someone near their target shape who wants a non-surgical approach and has realistic expectations. If you're weighing it up: choose a qualified, regulated practitioner; ask whether they use the newer-generation applicators; and make sure PAH is explained to you properly — what it is, roughly how likely, that you're higher risk if you're male or treating the abdomen, and that it would need surgery to fix.
A good practitioner will welcome those questions, because a proper consent conversation protects both of you. If a clinic won't discuss the risks frankly, that tells you something more useful than any before-and-after gallery.
The bottom line
Linda Evangelista's story is heartbreaking, and it's rare — both of those things are true, and holding them together is the whole job. CoolSculpting is, for most people, a safe and reasonable treatment with a small risk of a strange and stubborn complication. The problem was never that the risk existed; it's that she wasn't properly warned it did.
So take the reassurance and the caveat: the risk is genuinely small — and the honesty you're owed about it should be anything but.
References
Kelly ME, et al. A multicenter evaluation of paradoxical adipose hyperplasia following cryolipolysis for fat reduction and body contouring: a review of 8658 cycles in 2114 patients. Aesthetic Surgery Journal. 2021;41(8):932–941. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8279305/
Incidence of paradoxical adipose hyperplasia after cryolipolysis: a systematic review and meta-analysis. Aesthetic Surgery Journal Open Forum. 2025. Available from: https://pubmed.ncbi.nlm.nih.gov/41322038/
Paradoxical adipose hyperplasia — overview, presentation and management [Internet]. StatPearls / NCBI Bookshelf. Available from: https://www.ncbi.nlm.nih.gov/books/NBK606530/
Ashley E. CPD: Analysing Cryolipolysis. Aesthetics Journal. Available from: https://aestheticsjournal.com/cpd/cpd-analysing-cryolipolysis/
Linda Evangelista settles CoolSculpting (cosmetic procedure) lawsuit [Internet]. CNN. Available from: https://www.cnn.com/style/article/linda-evangelista-cosmetic-lawsuit-settled-intl-scli
Linda Evangelista settles CoolSculpting suit after "horrific ordeal" [Internet]. The Hollywood Reporter; 2022. Available from: https://www.hollywoodreporter.com/lifestyle/lifestyle-news/linda-evangelista-coolsculpting-suit-settled-disfigured-1235183868/
US Food and Drug Administration — cryolipolysis (CoolSculpting) device clearance and general information on non-invasive fat reduction [Internet]. Available from: https://www.fda.gov/
When supermodel Linda Evangelista revealed that a fat-freezing treatment had left her "brutally disfigured," it put a rare side effect of CoolSculpting on the front pages. For the clinician, this rare complication highlights how important proper consent in aesthetic medicine is.